TScan Therapeutics (Nasdaq: TCRX) is a clinical-stage biopharmaceutical company based in Waltham, Massachusetts developing T-cell receptor engineered T-cell (TCR-T) therapies for the treatment of patients with cancer.
company life-sciences immunotherapy oncology biotech apis-json cell-therapy biopharmaceutical clinical-stage tcr-t
-
Updated
Aug 8, 2026